Who is sponsoring NCT03499158?

NCT03499158 is sponsored by ASLIHAN UZUNKULAOGLU.

What drugs are being tested in NCT03499158?

Interventions in NCT03499158: nerve conduction study.

What condition does NCT03499158 study?

NCT03499158 studies Carpal Tunnel Syndrome.

Is NCT03499158 still recruiting?

NCT03499158 is currently completed. Last updated 17 April 2018.

Last reviewed 2018-04-17 · How we verify

NCT03499158

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Terminal Latency Index, Residual Latency and Median Ulnar F Latency Difference in Carpal Tunnel Syndrome

Completed Last updated 17 April 2018

What this trial tests

trial testing nerve conduction study in Carpal Tunnel Syndrome in 160 participants. Completed in 2 March 2016.

Timeline

1 January 2016

Primary endpoint
1 March 2016

2 March 2016

Quick facts

Lead sponsor	ASLIHAN UZUNKULAOGLU
Status	Completed
Study type	OBSERVATIONAL
Enrollment	160
Start date	1 January 2016
Primary completion	1 March 2016
Estimated completion	2 March 2016

Drugs / interventions tested

nerve conduction study

Conditions studied

Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

ASLIHAN UZUNKULAOGLU

Who can join

Adults 18 to 90, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Terminal latency index, residual latency and median ulnar F latency difference in carpal tunnel syndrome are specific parameters for the diagnosis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Terminal Latency Index, Residual Latency, and Median-Ulnar F-Wave Latency Difference in Carpal Tunnel Syndrome.
Uzunkulaoğlu A, Afsar SI, Tepeli B. · · 2019 · cited 4× · PMID 31007429 · DOI 10.4103/aian.aian_276_18

Verify or expand the search:

Other trials of nerve conduction study

Trials testing the same drug.

NCT06925256 — Considering Peripheral Nerve Injury, Is It Safe to Perform Transradial Angiography? · NA · not yet recruiting
NCT06186284 — Impact of Walking Aids on the Occurrence of Carpal Tunnel Syndrome in Rehabilitation · NA · completed

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03499158 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ASLIHAN UZUNKULAOGLU
Last refreshed: 17 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03499158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing